by Innovit Corporate Affairs | Jan 27, 2020 | Blog, MDR
European Commission announced last October that the new EUDAMED will not launch until May 2022, giving everyone enough time to properly prepare for implementing M2M data exchange with EUDAMED. Further, a grace period was also introduced by the EU for certain classes...
by Innovit Corporate Affairs | Jan 8, 2020 | Blog, Eudamed, GUDID
In September 2019, we witnessed PLM software giant, PTC Windchill, quietly exit the UDI compliance market. As we ended 2019, several little birds have shared that GHX is slated to phase out support for their UDI Data Submission Service and will not be providing a...
by Innovit Corporate Affairs | Jan 6, 2020 | Blog
Happy New Year! As the dust settles from the holiday madness and end-of-year celebrations, we thought we’d take a quick look back and reflect upon our 2019 journey. We’re so fortunate to work with an amazing roster of customers and partners whose relationships are...
by Innovit Corporate Affairs | Nov 25, 2019 | Blog, Eudamed
The European Commission recently announced that the new EUDAMED will not launch until May 2022, even as the MDR takes effect in May 2020. Given this postponement, we now have the opportunity, and sufficient time, to properly prepare for implementing M2M data...
by Innovit Corporate Affairs | Oct 16, 2019 | News
We are so proud to announce that after the initial round of EUDAMED Playground M2M Data Exchange testing, Innovit was the only solution provider able to successfully complete all the test cases for Device/UDI Registration. Those test results were published by the EU...
